Check-Cap (STU:7CC) Short Interest


STU:7CC Check-Cap Ltd STU:7CC
25 GF Score
Price €1.15
! 2 Warning Signs
View Full Analysis

What is Check-Cap Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:7CC vs XWEL, NDRA, NOTV: Short Interest Comparison

For the Diagnostics & Research subindustry, Check-Cap's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Check-Cap Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Check-Cap's Short Interest distribution charts can be found below:

* The bar in red indicates where Check-Cap's Short Interest falls into.


STU:7CC
25GF Score
Check-Cap Ltd STU:7CC
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Check-Cap Business Description

Other Exchanges MBAI:USA
Address 29 Abba Hushi Avenue, P.O. Box 1271, Mount Carmel, Isfiya, ISR, 3009000
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
25GF Score

Get the complete analysis for STU:7CC

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.15
Price